查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835208

胃肠内视镜设备市场按产品类型、可重复使用性、性别、年龄层、应用和最终用户划分－全球预测，2025-2032

Gastrointestinal Endoscopy Devices Market by Product Type, Reusability, Age Group, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，胃肠内视镜设备市场将成长至 241 亿美元，复合年增长率为 5.91%。

主要市场统计数据
基准年2024年 152.2亿美元
预计2025年 160.7亿美元
预测年份：2032年 241亿美元
复合年增长率（%） 5.91%

全面介绍重新说明胃肠内视镜设备优先顺序的临床需求、技术融合和采购动态

胃肠内视镜设备处于临床需求与快速技术进步的交汇点，其创新专注于提高诊断准确性、治疗能力和病人安全性。依赖内视镜可视化的诊疗程序支撑着从常规筛检到复杂介入治疗等各种临床路径。因此，临床、製造和医疗保健系统采购的相关人员优先考虑能够缩短手术时间、降低併发症发生率并与数位化医疗保健工作流程无缝整合的设备。

现代设备开发强调小型化、增强光学性能、人体工学设计和连接性，以支援影像导引介入和远端会诊。同时，监管和报销环境也在不断演变，以反映基于结果的护理和成本控制压力，要求製造商透过临床证据和工作流程效率来证明其价值。因此，研发投资与临床医生对能够在统一技术堆迭下进行诊断和治疗的平台日益增长的需求相契合。

在考虑策略定位时，了解临床趋势、采购行为和技术采用之间的相互关联至关重要。医院和专科诊所越来越多地评估其设备组合，不仅考虑每次手术的性能，还考虑生命週期成本、再处理负担以及与更广泛的企业影像系统的兼容性。这种动态为差异化产品设计、价值主导的服务产品以及涵盖从门诊筛检到住院干预的整个护理过程的伙伴关係关係提供了机会。

影像、感染控制重点和扩展治疗方法的飞跃如何重塑竞争动态和产品蓝图

近年来，随着临床需求与技术能力的融合，胃肠内视镜生态系统的竞争优势正在加速重塑。光学创新和高解析度成像增强了诊断能力，而数位平台与人工智慧的融合则增强了病变检测、手术记录和术后分析。这些技术进步极大地改变了人们的预期，要求设备製造商在产品设计早期就将软体、升级路径和互通性考虑纳入考量。

同时，业界正应对日益增长的感染控制和器械再处理方面的担忧。一次性平台正逐渐成为降低交叉污染风险和减轻复杂再处理工作流程营运负担的可行方案。这促使医疗保健系统重新评估其资本配置和基于耗材的模式，一些供应商更倾向于放弃器械所有权，换取可靠的一次性用品，以简化物流和合规性。

另一个重大转变是内视镜的作用从诊断扩展到微创治疗。用于腔内治疗（包括高级止血、组织切除和内视镜缝合）的设备使临床医生能够处理以前需要手术治疗的疾病。这种转变刺激了对支援各种介入手术的多功能平台和辅助设备的需求，从而重塑了围绕培训要求、操作指南和报销的讨论。这些转变正在重新定义整个价值链的产品蓝图和竞争策略。

2025 年美国新关税将如何影响内视镜设备相关人员的采购、购买行为和供应链弹性

2025年美国新关税的实施将对内视镜设备製造商和买家的采购、供应链设计和定价策略产生重大影响。关税主导进口零件和成品成本上涨，迫使製造商重新评估其全球采购布局，重新考虑供应商合同，并考虑采用近岸外包方案以减轻进口关税的影响。此类调整需要仔细评估总到岸成本、前置作业时间波动和供应商可靠性，尤其对于先进光学元件、照明系统和精密手术器械等专用零件而言。

医疗系统和采购联盟正在透过缩短合约週期并强调总拥有成本而非仅仅单位成本来应对这一挑战。机构层面的决策者正在仔细审查采购合同，以寻找基于数量的折扣、长期服务协议以及捆绑销售的机会，从而抵消与关税相关的成本上涨。在产品开发层面，製造商面临着许多选择，例如在地化组装、重新设计产品以纳入替代零件以及吸收更高的投入成本。

从策略角度来看，积极主动地沟通透明的价格调整并与客户合作制定分阶段实施计划的公司往往能够更有效地保持市场进入。此外，投资于供应链韧性（包括供应商多元化、策略性库存缓衝和敏捷製造）的公司，在关税相关影响下，更有能力稳定交货时间并维护客户信心。由于关税分类和处理方式会影响到岸成本，监管合规和文件记录变得更加重要，这凸显了协调一致的商业、法律和营运回应的必要性。

细緻的细分观点揭示了产品类型、可重复使用性、患者人口统计、应用和医疗保健环境如何推动差异化的策略选择

细分市场动态揭示了差异化的机会和限制因素，可为产品策略、商业化和临床应用提供参考。依产品类型，我们涵盖配件、内视镜、手术器械和视觉化设备。配件分为摄影机、导管导引线和插入管；内视镜分为软式内视镜内视镜和硬式内视镜；手术器械分为钳子、剪刀和勒除器；可视化设备分为摄影机、光源、监视器和视讯处理器。这种产品类型细分突显了模组化和可升级性如何影响购买偏好：医院青睐整合视觉化系统，而专科诊所则青睐支援所需手术的优化配件包。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 引入基于AI的病变检测系统，提高胃肠内视镜诊断的准确性和工作流程效率
  • 增加一次性内视镜的使用，以减少交叉污染风险并简化灭菌流程
  • 结合高解析度和窄频成像技术，改善黏膜可视化和早期疾病检测
  • 开发超薄经鼻内视镜以提高患者舒适度并扩大门诊手术
  • 扩展机器人内视镜平台，用于复杂胃肠手术的精确治疗性介入
  • 远端监控和远端监控解决方案变得越来越重要，扩大了农村和服务欠缺地区的专业人员的覆盖范围
  • 胃肠内视镜微创组织取样抛弃式切片检查和切除工具的进展
  • 对 3D 和萤光成像模式的需求不断增加，以协助即时肿瘤边缘评估和指导切片检查
  • 引入整合式水刀冲洗和抽吸系统，在长时间内视镜检查过程中保持最佳可视度

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 胃肠内视镜设备市场（依产品类型）

  • 配件
    • 相机
    • 导管导引线
    • 插入管
  • 内视镜检查
    • 软式内视镜
    • 硬式内视镜
  • 手术器械
    • 钳子
    • 剪刀
    • 勒除器
  • 视觉化设备
    • 相机
    • 光源
    • 监视器
    • 视讯处理器

9. 胃肠内视镜设备市场：可重复使用性别

  • 可重复使用内视镜
  • 免洗内视镜

第十章胃肠内视镜设备市场（依年龄层）

  • 成人
  • 老年人
  • 孩子们

第11章胃肠内视镜设备市场（依应用）

  • 诊断
  • 治疗

第12章胃肠内视镜设备市场（依最终用户）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章胃肠内视镜设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章胃肠内视镜设备市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各国胃肠内视镜设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Ambu A/S
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Cardinal Health
    • ConMed Corporation
    • Cook Medical, Inc.
    • Erbe Elektromedizin GmbH
    • Fujifilm Holdings Corporation
    • Johnson & Johnson
    • KARL STORZ SE & Co. KG
    • Medtronic plc
    • MICRO-TECH（Nanjing）Co., Ltd.
    • Olympus Corporation
    • PENTAX Medical America, Inc.
    • Richard Wolf GmbH
    • SB-KAWASUMI LABORATORIES, INC.
    • Smart Medical Systems Ltd.
    • Smith & Nephew plc
    • STERIS plc
    • Stryker Corporation
    • Teleflex Incorporated
Product Code: MRR-437E9896A4FC

The Gastrointestinal Endoscopy Devices Market is projected to grow by USD 24.10 billion at a CAGR of 5.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 15.22 billion
Estimated Year [2025] USD 16.07 billion
Forecast Year [2032] USD 24.10 billion
CAGR (%) 5.91%

A comprehensive introduction describing clinical imperatives, technology convergence, and procurement dynamics that are redefining gastrointestinal endoscopy device priorities

The gastrointestinal endoscopy device landscape sits at the intersection of clinical necessity and rapid technological advancement, with innovation focused on improving diagnostic accuracy, therapeutic capability, and patient safety. Procedures that rely on endoscopic visualization underpin a wide range of clinical pathways, from routine screening to complex interventional therapies. Consequently, stakeholders across clinical practice, manufacturing, and health-system procurement prioritize devices that reduce procedure time, lower complication rates, and integrate seamlessly with digital healthcare workflows.

Contemporary device development emphasizes miniaturization, enhanced optics, ergonomic design, and connectivity to support image-guided interventions and remote consultation. Simultaneously, regulatory and reimbursement environments are evolving to reflect outcomes-based care and cost-containment pressures, prompting manufacturers to demonstrate value through clinical evidence and workflow efficiency. As a result, investment in research and development converges with an increased appetite among clinicians for platforms that enable both diagnostics and therapeutics under a unified technology stack.

As you consider strategic positioning, it is vital to understand how clinical trends, procurement behavior, and technology adoption interrelate. Hospitals and specialty clinics increasingly evaluate device portfolios not only on per-procedure performance but on lifecycle costs, reprocessing burdens, and compatibility with broader enterprise imaging systems. This dynamic presents opportunities for differentiated product design, value-driven service offerings, and partnerships that address the full continuum of care from outpatient screening to inpatient interventions.

An incisive analysis of how imaging leaps, infection-control priorities, and therapeutic expansion are reshaping competitive dynamics and product roadmaps

Over recent years, transformative shifts have accelerated the redefinition of competitive advantage within the gastrointestinal endoscopy ecosystem, driven by converging clinical needs and technological capability. Optical innovations and higher-resolution imaging have elevated diagnostic performance, while the integration of digital platforms and artificial intelligence is enhancing lesion detection, procedural documentation, and post-procedural analytics. These technological advances are shifting expectations, requiring device manufacturers to embed software, upgrade pathways, and interoperability considerations early in product design.

Simultaneously, the industry is responding to heightened concerns around infection control and device reprocessing. Single-use platforms have gained attention as a pragmatic option to reduce cross-contamination risk and alleviate the operational burden of complex reprocessing workflows. This has triggered a re-evaluation of capital allocation versus consumable-based models among health systems, with some providers preferring to trade equipment ownership for reliable disposables that simplify logistics and regulatory compliance.

Another significant shift is the broadening role of endoscopy beyond diagnostics toward minimally invasive therapeutics. Devices that facilitate endoluminal therapies, including advanced hemostasis, tissue resection, and endoscopic suturing, are enabling clinicians to manage conditions that previously required surgery. This transition is spurring demand for multi-functional platforms and accessory instruments that support a spectrum of interventional procedures, which in turn is reshaping training requirements, procedural guidelines, and reimbursement conversations. Collectively, these shifts are redefining product roadmaps and competitive strategies across the value chain.

A strategic examination of how new United States tariff measures in 2025 are influencing sourcing, procurement behavior, and supply chain resilience for endoscopy device stakeholders

The implementation of new tariff measures in the United States during 2025 has introduced material implications for procurement, supply chain design, and pricing strategies for endoscopy device manufacturers and buyers. Tariff-driven cost inflations on imported components and finished goods are prompting manufacturers to reassess global sourcing footprints, revisit supplier agreements, and explore nearshoring options to mitigate exposure to import duties. These adjustments require a careful evaluation of total landed cost, lead-time variability, and supplier reliability, especially for specialized components such as advanced optics, illumination systems, and precision surgical instruments.

Health systems and purchasing consortia are reacting by tightening contracting cycles and amplifying emphasis on total cost of ownership rather than unit price alone. Facility-level decision-makers are scrutinizing procurement contracts to identify opportunities for volume-based discounts, long-term service agreements, and bundled offerings that can offset incremental tariff-related costs. At the product development level, manufacturers face choices between localizing assembly, redesigning products to incorporate alternative components, or absorbing higher input costs, each with implications for margins and time-to-market.

From a strategic standpoint, businesses that proactively communicate transparent pricing adjustments and collaborate with customers on phased implementation plans tend to preserve market access more effectively. Additionally, organizations that invest in supply chain resilience-through diversified supplier networks, strategic inventory buffers, and agile manufacturing arrangements-are better positioned to stabilize delivery and maintain customer confidence amid tariff-related disruptions. Regulatory compliance and documentation become more central as customs classifications and duty treatments influence landed cost, underscoring the need for coordinated commercial, legal, and operational responses.

A nuanced segmentation perspective illuminating how product type, reusability, patient demographics, application, and care setting drive differentiated strategic choices

Segment-level dynamics reveal differentiated opportunities and constraints that inform product strategy, commercialization, and clinical adoption. Based on Product Type the market covers Accessories, Endoscopes, Operative Devices, and Visualization Equipment, with Accessories further studied across Cameras, Guide Wires, and Insertion Tubes, Endoscopes further divided into Flexible Endoscopes and Rigid Endoscopes, Operative Devices examined through Forceps, Scissors, and Snares, and Visualization Equipment broken down into Cameras, Light Sources, Monitors, and Video Processors. This product-type granularity highlights how modularity and upgradeability shape purchasing preferences, with hospitals often favoring integrated visualization systems and specialty clinics opting for optimized accessory bundles that support targeted procedures.

Based on Reusability the market differentiates between Reusable Endoscopes and Single-use Endoscopes, a segmentation that directly relates to institutional priorities around infection control, reprocessing capacity, and lifecycle economics. Based on Age Group devices and procedural pathways are considered across Adults, Geriatrics, and Pediatrics, prompting tailored design considerations such as channel size, scope flexibility, and anesthesia requirements to accommodate patient cohorts with distinct anatomical and clinical risk profiles. Based on Application the division between Diagnostics and Therapeutics signals divergent value propositions: diagnostic platforms prioritize imaging fidelity and lesion detection adjuncts, while therapeutic devices emphasize instrument channel compatibility, accessory integration, and force transmission for interventional tasks.

Based on End User the market is studied across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics, each setting presenting unique procurement models, capital constraints, and throughput expectations. Ambulatory centers often prioritize rapid turnover and compact footprint solutions that optimize procedural volume, whereas hospitals require devices that support a broader case mix and cross-departmental interoperability. Specialty clinics focus on niche procedural excellence, adopting devices that deliver high-performance outcomes for focused indications. Understanding how these segments interact and where adoption curves accelerate provides the basis for tailored go-to-market strategies and product roadmaps.

A cross-regional analysis revealing how clinical demand patterns, regulatory diversity, and market infrastructure shape differentiated adoption pathways across global territories

Regional conditions govern clinical demand, regulatory pathways, and commercial models, shaping both near-term adoption patterns and longer-term strategic investments. In the Americas, healthcare delivery is characterized by a mix of high-volume academic centers, large integrated delivery networks, and proliferating outpatient facilities, which together create demand for scalable platforms that offer interoperability and strong clinical evidence to support reimbursement. Reimbursement frameworks and value-based purchasing initiatives increasingly influence procurement cycles, motivating vendors to present robust health economic data and service models that reduce total procedural cost.

In Europe, Middle East & Africa regulatory harmonization in some jurisdictions coexists with varied reimbursement regimes and infrastructure maturity across countries, requiring tailored market-entry plans. Manufacturers often prioritize regulatory approvals and local clinical partnerships to accelerate adoption, while flexible financing and training programs can overcome capacity constraints in emerging markets. The Asia-Pacific region demonstrates fast-paced adoption in urban tertiary centers paired with distinct procurement behaviors driven by public health priorities, local manufacturing ecosystems, and an expanding network of private specialty clinics. Growth in procedure volumes, investments in digital health, and rising emphasis on minimally invasive care are notable drivers.

Across regions, successful commercial strategies combine global platform consistency with localized value propositions, including language-specific software interfaces, tailored training curricula, and reimbursement support. Vendors that invest in regional clinical evidence generation and build robust service networks tend to sustain adoption momentum by addressing the specific operational and regulatory pain points that vary from one geography to another.

A decisive appraisal of company-level strengths showing why technological breadth, clinical evidence, and comprehensive service ecosystems determine market leadership

Market leadership reflects a combination of technological depth, clinical engagement, and comprehensive service offerings. Leading device-makers invest in end-to-end solutions that span optics, accessory ecosystems, and integrated visualization platforms to deliver consistent procedural experiences across care settings. Strategic partnerships between capital equipment manufacturers and consumables suppliers create defensible value propositions by lowering barriers to platform switching and offering bundled service packages that simplify budgeting and maintenance.

Companies that prioritize clinical evidence generation through multicenter studies and investigator-led research are better positioned to influence guideline development and secure favorable formulary placement within hospital systems. Equally, those that invest in scalable training and education programs build clinician familiarity and procedural confidence, accelerating adoption of advanced therapeutic features. From an operational perspective, strong aftermarket service capabilities-including rapid parts replacement, remote diagnostics, and preventive maintenance-are decisive factors in long-term customer retention.

Emerging entrants are differentiating on specific dimensions such as single-use technologies, AI-enabled diagnostic support, and purpose-built devices for niche procedures. These focused strategies can yield rapid uptake in targeted segments, particularly when supported by compelling clinical outcomes and streamlined procurement packages. For established players, sustaining competitive advantage requires continuous platform evolution, investment in interoperable software ecosystems, and proactive engagement with payer and provider stakeholders to align product value with evolving care pathways.

A set of pragmatic, high-impact recommendations guiding leaders to align product architecture, supply resilience, and clinical evidence for sustained competitive advantage

Industry leaders must act with clarity and agility to translate emerging trends into durable competitive advantage. First, invest in product modularity and interoperability so platforms can evolve through software upgrades and accessory refreshes rather than complete hardware replacement, preserving customer loyalty and lowering adoption friction. Concurrently, expand clinical evidence programs that demonstrate not only procedural efficacy but also downstream health-economic benefits; such data helps to secure placement in value-driven purchasing models and supports favorable reimbursement conversations.

Second, strengthen supply chain resilience through diversification, strategic regional partnerships, and nearshoring options for critical components. This reduces exposure to tariff shocks, logistics disruptions, and component scarcity while enabling faster response to localized demand spikes. Third, develop differentiated service models that integrate preventative maintenance, digital monitoring, and tiered support contracts to create recurring revenue streams and deepen customer relationships. Attention to training and clinician adoption is also essential; comprehensive curricula and proctoring programs accelerate safe uptake of therapeutic capabilities and broaden the addressable market for complex procedures.

Finally, pursue targeted commercial strategies by aligning offerings with the specific needs of ambulatory surgery centers, hospitals, and specialty clinics. For ambulatory centers emphasize compact, cost-effective workflows; for hospitals prioritize cross-departmental interoperability and robustness; and for specialty clinics highlight performance attributes tailored to niche indications. By aligning R&D, commercialization, and supply chain strategies to these priorities, organizations can capture sustainable growth while mitigating operational risk.

A clear exposition of the mixed-method research approach combining clinician interviews, literature synthesis, and triangulation to validate technological and commercial insights

The research methodology blends primary and secondary approaches to ensure analytical rigor and practical relevance. Primary research drew on structured interviews with clinicians, procurement leaders, clinical engineers, and senior executives across device manufacturers, conducted to surface real-world adoption drivers, operational pain points, and procurement practices. These firsthand insights were supplemented by targeted consultations with regulatory and reimbursement experts to contextualize market access barriers and facilitators across different jurisdictions.

Secondary research included systematic reviews of peer-reviewed clinical literature, professional society guidelines, patent filings, and publicly available regulatory documentation to ground technological and clinical assertions in established evidence. Trade publications, conference proceedings, and company disclosures were analyzed to capture product launches, strategic partnerships, and modality-specific innovations. Data triangulation procedures compared findings across sources to validate trends and resolve discrepancies.

Analytical techniques included thematic coding of qualitative interviews, comparative assessment of device feature sets, and scenario analysis to evaluate supply chain and regulatory contingencies. Quality assurance engaged independent subject-matter reviewers to assess methodological soundness and factual accuracy. Where uncertainties remain, the methodology explicitly documents assumptions and recommends areas for future primary study to close evidence gaps.

A conclusive synthesis highlighting why integration of clinical evidence, resilient operations, and targeted commercialization will define success in gastrointestinal endoscopy devices

In summary, the gastrointestinal endoscopy device environment is evolving under the combined influence of imaging advances, infection-control imperatives, and the expanding role of endoscopic therapeutics. These forces are reshaping product design priorities, commercial models, and the structure of clinical workflows. Manufacturers that align platform strategies with interoperability, evidence generation, and service excellence will be best positioned to meet the changing demands of hospitals, ambulatory centers, and specialty clinics.

Supply chain robustness and strategic responses to tariff developments are immediate operational priorities, while long-term competitiveness hinges on modular architectures and software-enabled value propositions. Segmentation insights underscore the need for differentiated offerings across product types, reusability profiles, patient age groups, applications, and end-user settings. Regional nuances reinforce the value of localized strategies that reflect regulatory processes, reimbursement mechanisms, and infrastructure maturity.

Overall, organizations that integrate clinical insight, operational resilience, and targeted commercialization will be well placed to convert technological opportunity into sustainable market performance, while delivering improved patient outcomes and procedural efficiencies across the continuum of gastrointestinal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-enabled lesion detection systems to improve diagnostic accuracy and workflow efficiency in GI endoscopy
  • 5.2. Rising utilization of disposable endoscopes to reduce cross-contamination risks and streamline sterilization processes
  • 5.3. Integration of high-definition and narrow-band imaging technologies for enhanced mucosal visualization and early disease detection
  • 5.4. Development of ultrathin transnasal endoscopes for improved patient comfort and expanded outpatient procedure adoption
  • 5.5. Expansion of robotics-assisted endoscopic platforms for precise therapeutic interventions in complex GI procedures
  • 5.6. Growing emphasis on telemonitoring and remote proctoring solutions to extend specialist reach in rural and underserved areas
  • 5.7. Advancements in single-use biopsy and resection tools for minimally invasive tissue sampling during GI endoscopy
  • 5.8. Increasing demand for 3D and fluorescence imaging modalities to aid real-time tumor margin assessment and guided biopsies
  • 5.9. Emergence of integrated waterjet irrigation and suction systems to maintain optimal visibility during prolonged endoscopic procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Endoscopy Devices Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Cameras
    • 8.1.2. Guide Wires
    • 8.1.3. Insertion Tubes
  • 8.2. Endoscopes
    • 8.2.1. Flexible Endoscopes
    • 8.2.2. Rigid Endoscopes
  • 8.3. Operative Devices
    • 8.3.1. Forceps
    • 8.3.2. Scissors
    • 8.3.3. Snares
  • 8.4. Visualization Equipment
    • 8.4.1. Cameras
    • 8.4.2. Light Sources
    • 8.4.3. Monitors
    • 8.4.4. Video Processors

9. Gastrointestinal Endoscopy Devices Market, by Reusability

  • 9.1. Reusable Endoscopes
  • 9.2. Single-use Endoscopes

10. Gastrointestinal Endoscopy Devices Market, by Age Group

  • 10.1. Adults
  • 10.2. Geriatrics
  • 10.3. Pediatrics

11. Gastrointestinal Endoscopy Devices Market, by Application

  • 11.1. Diagnostics
  • 11.2. Therapeutics

12. Gastrointestinal Endoscopy Devices Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Gastrointestinal Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Ambu A/S
    • 16.3.3. Becton, Dickinson and Company
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Cardinal Health
    • 16.3.6. ConMed Corporation
    • 16.3.7. Cook Medical, Inc.
    • 16.3.8. Erbe Elektromedizin GmbH
    • 16.3.9. Fujifilm Holdings Corporation
    • 16.3.10. Johnson & Johnson
    • 16.3.11. KARL STORZ SE & Co. KG
    • 16.3.12. Medtronic plc
    • 16.3.13. MICRO-TECH (Nanjing) Co., Ltd.
    • 16.3.14. Olympus Corporation
    • 16.3.15. PENTAX Medical America, Inc.
    • 16.3.16. Richard Wolf GmbH
    • 16.3.17. SB-KAWASUMI LABORATORIES, INC.
    • 16.3.18. Smart Medical Systems Ltd.
    • 16.3.19. Smith & Nephew plc
    • 16.3.20. STERIS plc
    • 16.3.21. Stryker Corporation
    • 16.3.22. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. GASTROINTESTINAL ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-